0001209191-20-057330.txt : 20201106
0001209191-20-057330.hdr.sgml : 20201106
20201106173848
ACCESSION NUMBER: 0001209191-20-057330
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20201104
FILED AS OF DATE: 20201106
DATE AS OF CHANGE: 20201106
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kamal Mostafa
CENTRAL INDEX KEY: 0001647234
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-06639
FILM NUMBER: 201295467
MAIL ADDRESS:
STREET 1: 15950 NORTH 76TH STREET, #200
CITY: SCOTTSDALE
STATE: AZ
ZIP: 85260
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: MAGELLAN HEALTH INC
CENTRAL INDEX KEY: 0000019411
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-HOSPITALS [8060]
IRS NUMBER: 581076937
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4801 E. WASHINGTON ST
CITY: PHOENIX
STATE: AZ
ZIP: 85034
BUSINESS PHONE: 800-642-1716
MAIL ADDRESS:
STREET 1: 4801 E. WASHINGTON ST
CITY: PHOENIX
STATE: AZ
ZIP: 85034
FORMER COMPANY:
FORMER CONFORMED NAME: MAGELLAN HEALTH SERVICES INC
DATE OF NAME CHANGE: 19960226
FORMER COMPANY:
FORMER CONFORMED NAME: CHARTER MEDICAL CORP
DATE OF NAME CHANGE: 19920703
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-11-04
0
0000019411
MAGELLAN HEALTH INC
MGLN
0001647234
Kamal Mostafa
4801 EAST WASHINGTON STREET
PHOENIX
AZ
85034
0
1
0
0
CEO, Magellan Rx Management
Ordinary Common Stock, $0.01 par value
2020-11-04
4
X
0
3434
64.87
A
9051
D
Ordinary Common Stock, $0.01 par value
2020-11-04
4
S
0
3434
79.8925
D
5617
D
Ordinary Common Stock, $0.01 par value
2020-11-05
4
X
0
3589
64.87
A
9206
D
Ordinary Common Stock, $0.01 par value
2020-11-05
4
S
0
3589
79.87
D
5617
D
Stock Option (right to buy)
64.87
2020-11-04
4
X
0
3434
0.00
D
2026-03-03
Common Stock
3434
3589
D
Stock Options (right to buy)
64.87
2020-11-05
4
X
0
3589
0.00
D
2026-03-03
Common Stock
3589
0
D
This transaction was effectuated pursuant to a Rule 10b-5-1 Plan.
The number of securities reported represents an aggregate number of shares sold in multiple open market transactions at an average price of $79.8925. The price reported represents the weighted average price. The Reporting Person undertakes to provide staff of the SEC, the issuer, or a stockholder of the issuer, upon request, the number of shares sold by the Reporting Person at each separate price within the range.
All of the stock options in this tranche have vested in full.
Not applicable.
This transaction was effectuated pursuant to a Rule 10b-5-1 Plan.
/s/ Mostafa Kamal
2020-11-06